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Background: Few studies have investigated the validity of mainstream wrist-based activity trackers in healthy older adults in
real life, as opposed to laboratory settings.
Objective: This study explored the performance of two wrist-worn trackers (Fitbit Charge 2 and Garmin vivosmart HR+) in
estimating steps, energy expenditure, moderate-to-vigorous physical activity (MVPA) levels, and sleep parameters (total sleep
time [TST] and wake after sleep onset [WASO]) against gold-standard technologies in a cohort of healthy older adults in a
free-living environment.
Methods: Overall, 20 participants (>65 years) took part in the study. The devices were worn by the participants for 24 hours,
and the results were compared against validated technology (ActiGraph and New-Lifestyles NL-2000i). Mean error, mean
percentage error (MPE), mean absolute percentage error (MAPE), intraclass correlation (ICC), and Bland-Altman plots were
computed for all the parameters considered.
Results: For step counting, all trackers were highly correlated with one another (ICCs>0.89). Although the Fitbit tended to
overcount steps (MPE=12.36%), the Garmin and ActiGraph undercounted (MPE 9.36% and 11.53%, respectively). The Garmin
had poor ICC values when energy expenditure was compared against the criterion. The Fitbit had moderate-to-good ICCs in
comparison to the other activity trackers, and showed the best results (MAPE=12.25%), although it underestimated calories
burned. For MVPA levels estimation, the wristband trackers were highly correlated (ICC=0.96); however, they were moderately
correlated against the criterion and they overestimated MVPA activity minutes. For the sleep parameters, the ICCs were poor for
all cases, except when comparing the Fitbit with the criterion, which showed moderate agreement. The TST was slightly
overestimated with the Fitbit, although it provided good results with an average MAPE equal to 10.13%. Conversely, WASO
estimation was poorer and was overestimated by the Fitbit but underestimated by the Garmin. Again, the Fitbit was the most
accurate, with an average MAPE of 49.7%.
Conclusions: The tested well-known devices could be adopted to estimate steps, energy expenditure, and sleep duration with
an acceptable level of accuracy in the population of interest, although clinicians should be cautious in considering other parameters
for clinical and research purposes.
(JMIR Mhealth Uhealth 2019;7(6):e13084)  doi: 10.2196/13084
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Fitness trackers are popular devices used by athletes and the
general public to monitor their physical activity levels, sport
performance, and even their general health status in real time,
with the latter having the potential to also predict the person’s
future health status [1]. Compared to other body positions, the
wrist has been identified as the most suitable location for
enhancing user acceptability and the user-friendliness of the
device [2]. Common consumer-level, wrist-worn devices
typically provide data on step count, distance traveled, number
of floors climbed, and minutes of physical activity, as well as
sport-related activity recognition, physiological measurements,
energy expenditure, and sleep patterns. This information can
promote a healthier lifestyle or an optimal training program
through user-friendly visual feedback of current status or
performance compared to set targets.
Fitness trackers based on motion sensors are also being used
for monitoring biomechanical quantities of clinical interest,
such as gait analysis applications [3,4], indirect estimation of
ground reaction forces, and posture in general [5,6].
Although the number of studies investigating the validity and
reliability of different fitness trackers is growing, the majority
of the evidence is limited to young and middle-aged adult
populations, mostly in good health [7-9]. Considering the
multiple applications of wrist-based technology and its potential
adoption in health care, and with an aging population, it is
important to investigate the use of these devices in different
populations, such as older people [10]. Although older adults
perceive commercial trackers as useful and acceptable [11,12],
older person-specific activity trackers are still limited [13].
Few studies have investigated the validity of mainstream
wrist-based activity trackers in healthy older adults [14,15].
However, such investigations mainly involved a protocol
structured around a number of daily activities simulated or
recreated in a laboratory environment. Studies that investigated
fitness trackers’ performance when used by older people in their
home environment, where older adults can perform their real
daily routine, are scarce and mainly limited to step-counting
features [16]. This study reviewed the validity and reliability
of consumer-grade activity trackers in older
community-dwelling adults through seven observational studies,
of which only five studied free-living settings for a monitoring
period of between 3 and 7 days.
For example, Paul et al [17] reported that the average steps per
day measured over 7 days in a community-dwelling older adult
population with a Fitbit and an ActiGraph showed excellent
agreement, with the ActiGraph undercounting steps compared
against participants’ physical activity logs.
In another study, a Fitbit Flex and an ActiGraph were worn by
a cohort of cardiac patients and their family members to measure
steps and moderate-to-vigorous physical activity (MVPA) levels
for 4 days [18]. It showed a significant correlation for step
counts but lower values for MVPA, with the Fitbit Flex slightly
overestimating both parameters.
Boeselt et al [19] compared a Polar A300 with a BodyMedia
SenseWear in a cohort of patients with chronic obstructive
pulmonary disease (mean age 66.4 years). Participants used the
devices for three consecutive days, measuring steps, calories
burned, daily activity time, and metabolic equivalents. The study
showed a high correlation for step count and calories burned.
Farina and Lowry [20] compared the accuracy of step counts
from two consumer-level activity monitors (Misfit Shine on
both wrist and waist, and Fitbit Charge HR on the wrist) against
two waist-worn reference devices (ActiGraph GT3X+ and New
Lifestyle NL2000i) in healthy, community-dwelling older adults
in free-living conditions over seven consecutive days. All
consumer-level activity monitors positively correlated with
reference devices. Compared to the ActiGraph GT3X+, the
waist-worn Misfit Shine displayed the highest agreement,
whereas the wrist-worn devices showed poorer performances.
Finally, Burton et al [21] reported good reliability and validity
for the Fitbit Flex and Fitbit Charge HR compared against a
GENEactiv accelerometer in a free-living environment over 14
days. Step count, distance traveled, MVPA minutes, and sleep
were measured. Good strength of agreement was found for total
distance and steps (obtained with the fitness tracker) and the
MVPA estimated by the GENEactiv.
It is evident that a comparative analysis of mainstream trackers
worn by healthy older people in a more ecologically valid
environment is needed. This study aims to investigate the
reliability and accuracy of the wrist-based Fitbit Charge 2 and
the Garmin vivosmart HR+ activity trackers in the estimation
of daily step count, total calorie expenditure, MVPA, and sleep




This study was based on a sample of 20 healthy older people
(9 males, 11 females). Volunteers were recruited via a general
invitation email, posters, and word of mouth to exstaff at
University College Cork (Cork, Ireland) and their relatives, and
also through local social and voluntary groups that had older
adults as members. They were informed of the study by the
Centre for Gerontology and Rehabilitation in University College
Cork.
For the cohort, the inclusion criteria were age 65 years and
older, with no history of neurological or other disorders or
disability that could affect the participant’s movements, and in
good general health. Before participation, volunteers received
an oral and written explanation of the study protocol, and written
consent was obtained. Sociodemographic information was
collected on gender, age, weight, height, and dominant arm.
The study received approval by the Clinical Research Ethics
Committee at the University College Cork. Demographic
information on the participants who completed the study
protocol is presented in Table 1.
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Table 1. Participant characteristics (N=20).
Females (n=11)Males (n=9)Characteristic
71.1 (3.1)70.2 (2.9)Age (years), mean (SD)
161.1 (6.9)176.8 (4.7)Height (cm), mean (SD)
65.9 (9.3)81.6 (12.5)Weight (kg), mean (SD)
109People with right dominant arm, n
10People with left dominant arm, n
Equipment
The following consumer-level and research-grade devices were
selected for comparison:
1. Fitbit Charge 2 (Fitbit Inc, San Francisco, CA, USA): a
wrist-based device with a large organic light-emitting diode
screen featuring heartrate monitoring and tracking of steps,
distance, calories burned, floors climbed, active minutes,
and sleep duration.
2. Garmin vivosmart HR+ (Garmin, Olathe, KS, USA): a
wrist-based device that monitors heart rate, calories burned,
intensity of fitness activities, distance, time, and pace for
indoor or outdoor activities.
3. ActiGraph GT9X-BT (ActiGraph LLC, Pensacola, FL,
USA): a research-grade activity monitor based on motion
sensors that provide raw data and numerous activity and
sleep measures (eg, activity counts, energy expenditure,
steps taken, activity/sedentary bouts, sleep
latency/efficiency) via publicly available validated
algorithms. The device can be worn on the waist, hip, wrist,
ankle, or thigh.
4. New-Lifestyles NL-2000i Activity Monitor (New-Lifestyles
Inc, Lee’s Summit, MO, USA): a research-grade
measurement tool for data collection based on a
three-dimensional piezoelectric accelerometer. The device
can provide details on steps, MVPA, total/active calories,
and distance, and can store data for 7 to 14 days. Examples
of studies that have validated the pedometer are available
[20,22-24].
Experimental Protocol
Two consumer-based wrist-mounted brands were tested (Fitbit
and Garmin), worn on the nondominant arm. The trackers’
position on the wrist was randomized. The dominant side of the
waist (midaxillary line) and the dominant wrist are reported to
be optimal for monitoring energy expenditure, MVPA, and
sleep in older adults [25-28]; therefore, two ActiGraph monitors
were located in these positions as a reference for those
parameters. Energy expenditure, MVPA levels, and steps were
measured with the ActiGraph on the waist; sleep parameters
were extrapolated from the ActiGraph on the wrist. The
New-Lifestyles NL-2000i tracker was also worn on the dominant
waist (midaxillary line) and was considered as a reference for
step counting. Figure 1 illustrates the body positions of the
different devices on a participant.
The algorithm adopted by the ActiGraph for estimating energy
expenditure was based on the method designed by Crouter et
al [29] and also considered in Patterson et al [26]. This method
provides estimations expressed in metabolic equivalent (MET),
which are later converted into total calories per day. Likewise,
the algorithms of Troiano et al [30] and Cole-Kripke et al [31]
were considered for estimating MVPA levels and sleep
parameters, respectively, through the ActiGraph accelerometer
[28,32]. By definition, MVPA level is the amount of time spent
performing any activities requiring more than 3 METs, which
according to Troiano et al [30] is defined by the ActiGraph by
at least 2020 counts per minute. Finally, to guarantee a fair
comparison for the different trackers, only the sleep parameters
measured by both the Fitbit and Garmin were analyzed. Those
parameters were the total sleep time (TST), and the wake after
sleep onset (WASO). Participants were asked to complete a
sleep diary as well, and the in-bed and out-bed information
required by the Cole-Kripke method were input manually
according to the values reported in the sleep diary.
The devices were attached on to the person in the morning for
data collection and were returned to the researchers the
following morning. All trackers were removed by the
participants during bathing, whereas only the trackers on the
waist were removed during sleep.
Nonwear periods were defined as 90 minutes or more with no
activity counts [33]. A valid day was defined as 10 wearing
hours or more in a 24-hour period [30].
Statistical Analysis
Descriptive statistics were run on the computed parameters. The
following indicators were computed for each parameter and
device: mean estimated value with related standard deviation
(SD), mean bias with standard deviation, mean percentage error
(MPE) with standard deviation, and mean absolute percentage
error (MAPE). Intraclass correlation (ICC[2,1]) was performed
for each tracker compared against all other devices and the
criterion as well. The related 95% confidence intervals (CIs)
were also computed. ICC values less than 0.5, between 0.5 and
0.75, between 0.75 and 0.9, and greater than 0.90 are indicative
of poor, moderate, good, and excellent reliability, respectively
[34]. Bland-Altman plots were also obtained for every parameter
comparing all the possible permutations of trackers and the
criterion. All statistical analyses were performed using
MATLAB (MathWorks, Natick, MA, USA).
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Figure 1. Placement of devices on a participant.
Results
Overall, 20 participants took part in the data collection. All
participants were white of Irish and British ancestry. Data
collection was carried out at the Tyndall National Institute
between April 2018 and August 2018.
Table 2 shows the mean values measured, mean error, mean
percentage error, and MAPE with related standard deviations
for the activity monitors and each parameter. Likewise, Table
3 shows the related ICCs with the 95% CI for each tracker and
every parameter. Figure 2 displays the MAPE.
The average wear time for each tracker among all participants
was mean 963 (SD 102) minutes per day; thus, every monitored
day for each participant was deemed a valid test day above the
10 wearing hours threshold. All monitored days were on
weekdays.
For step counting, all the trackers were highly correlated with
one another (ICCs>0.89). Although the Fitbit tended to
overcount steps (MPE=12.36%), the Garmin and ActiGraph
undercounted with a MPE of 9.36% and 11.53%, respectively.
For the MAPE, the Garmin and ActiGraph were slightly more
accurate with mean MAPEs of 12.89% and 14.23%,
respectively. Therefore, all the considered activity trackers can
accurately capture steps when worn on the nondominant wrist.
However, the Garmin had poor ICC values when comparing
energy expenditure against the New-Lifestyles NL-2000i and
the criterion. Likewise, similar results were shown when
comparing the New-Lifestyles NL-2000i and the criterion.
Conversely, the Fitbit had moderate-to-good ICCs compared
against the other activity trackers. All the tested activity
monitors underestimated the amount of calories burned, with
the Fitbit showing the best results with a MAPE of 12.25%.
For MVPA level estimation, the Fitbit and Garmin were highly
correlated (ICC=0.96), whereas the New-Lifestyles NL-2000i
showed poor correlation with these two devices. However, all
monitors were moderately correlated against the criterion. The
Fitbit and Garmin overestimated the minutes of MVPA activity
(mean 12.63, SD 28.31 and mean 13.8, SD 35.7 minutes per
day), whereas New-Lifestyles-2000i underestimated, although
it showed the best MAPE results, at 45.45%, suggesting that
consumer-grade activity trackers may not be reliable in
estimating MVPA in older adults.
When analyzing the sleep parameters, the ICCs were poor for
all cases, except when comparing the Fitbit to the criterion,
which showed a moderate agreement. The TST was slightly
overestimated with the Fitbit (mean 5.72, SD 49.11 minutes),
although it provided good results with a mean MAPE equal to
10.13%. Conversely, the WASO estimation was poorer; it was
overestimated by the Fitbit but underestimated by the Garmin.
Again, the Fitbit was the most accurate, with a mean MAPE of
49.7%.
The Bland-Altman plots are shown in Figures 3-6 for steps,
energy expenditure, MVPA, and sleep parameters, respectively,
and summarized in Table 4.
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Table 2. Mean values measured, mean error, mean percentagage error, and mean absolute percentage error with related standard deviation for each
parameter and tracker (N=20).
MAPEb (SD)MPEa (SD)Mean error (SD)Mean (SD)Parameter
Steps
17.05 (13.71)12.36 (18.26)698.60 (1491.27)10088.45 (5067.32)Fitbit
12.90 (16.16)–9.36 (18.55)–555.00 (928.11)8834.85 (5067.07)Garmin
14.23 (7.76)–11.53 (11.55)–1014.15 (846.81)8375.70 (4716.39)ActiGraph
Energy expenditure (cal)
12.26 (7.33)–6.98 (12.67)–175.70 (293.18)2324.25 (547.02)Fitbit
20.05 (18.04)–2.09 (27.27)–65.30 (682.94)2434.65 (804.12)Garmin
16.70 (6.3)–14.61 (10.41)–397.65 (306.13)2102.30 (256.93)NL2000i
MVPAc (min)
75.74 (75.32)31.78 (103.51)12.63 (28.31)44.32 (45.83)Fitbit
91.98 (47.13)6.42 (109.75)13.80 (35.70)39.10 (57.18)Garmin
45.45 (29.67)–41.43 (35.37)–11.70 (18.45)20.30 (19.03)NL2000i
TSTd (min)
10.14 (9.12)2.27 (13.66)5.72 (49.11)389.83 (59.33)Fitbit
16.86 (13.3)15.85 (14.56)55.39 (48.07)442.83 (48.64)Garmin
WASOe (min)
49.73 (72.03)25.02 (84.72)0.21 (22.15)49.21 (16.5)Fitbit
66.89 (28.61)–66.89 (28.61)–35.86 (22.13)13.14 (8.93)Garmin
aMPE: mean percentage error.
bMAPE: mean absolute percentage error.
cMVPA: moderate-to-vigorous physical activity.
dTST: total sleep time.
eWASO: wake after sleep onset.
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0.95 (0.87, 0.98)—0.89 (0.39, 0.97)0.93 (0.65, 0.98)—aFitbit
0.98 (0.93, 0.99)—0.98 (0.94, 0.99)——Garmin
0.97 (0.59, 0.99)————ActiGraph (waist)
Energy expenditure
0.80 (0.48, 0.92)0.66 (0.21, 0.86)—0.64 (0.29, 0.84)—Fitbit
0.48 (0.05, 0.76)0.32 (–0.07, 0.65)———Garmin
0.45 (–0.10, 0.78)————NL2000i
    MVPAb
0.69 (0.35, 0.87)0.41 (–0.01, 0.72)—0.96 (0.86, 0.99)—Fitbit
0.68 (0.18, 0.91)0.46 (–0.11, 0.82)——Garmin
0.60 (0.18, 0.83)————NL2000i
    TSTc
0.67 (0.30, 0.86)——0.43 (–0.10, 0.77)—Fitbit
0.42 (–0.10, 0.76)————Garmin
   WASOd
0.32 (–0.28, 0.72)——<0.01 (–0.08, 0.18)—Fitbit
0.01 (–0.10, 0.25)————Garmin
aNot applicable.
bMVPA: moderate-to-vigorous physical activity.
cTST: total sleep time.
dWASO: wake after sleep onset.
JMIR Mhealth Uhealth 2019 | vol. 7 | iss. 6 | e13084 | p. 6https://mhealth.jmir.org/2019/6/e13084/
(page number not for citation purposes)
Tedesco et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Figure 2. Mean absolute percentage error (MAPE) with standard deviation for each parameter and tracker. EE: energy expenditure; MVPA:
moderate-to-vigorous physical activity; TST: total sleep time; WASO: wake after sleep onset.
Figure 3. Bland-Altman plots for steps.
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Figure 4. Bland-Altman plots for energy expenditure.
Figure 5. Bland-Altman plots for moderate-to-vigorous physical activity.
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Figure 6. Bland-Altman plots for sleep parameters. Top row: total sleep time; bottom row: wake after sleep onset.
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698.60 (1491.27)—1712.75 (1726.43)1253.60 (1437.60)—aMean error (SD)
–2224.29, 3621.49—–1671.05, 5096.55–1564.09, 4071.29—95% LoAb
Garmin
–555 (928.11)—459.15 (969.78)——Mean error (SD)
–2374.10, 1264.10—–1441.62, 2359.92——95% LoA
ActiGraph (waist)




–175.7 (293.18)221.95 (309.00)—–110.40 (586.13)—Mean error (SD)
–750.34, 398.94–383.69, 827.59—–1259.21, 1038.41—95% LoA
Garmin
–65.3 (682.94)332.35 (671.37)———Mean error (SD)
–1403.87, 1273.27–983.53, 1648.23———95% LoA
NL2000i




12.63 (28.31)23.95 (35.55)—6.20 (16.12)—Mean error (SD)
–42.86, 68.13–45.73, 93.63—–25.39, 37.79—95% LoA
Garmin
13.80 (35.70)22.60 (43.29)———Mean error (SD)
–56.18, 83.78–62.25, 107.45——95% LoA
NL2000i




5.72 (49.11)——–56.76 (45.99)—Mean error (SD)
–90.53, 101.97——–146.92, 33.39—95% LoA
Garmin




0.21 (22.15)——36.07 (18.91)—Mean error (SD)
–43.21, 43.64——–0.99, 73.14—95% LoA
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–35.86 (22.13)————Mean error (SD)
–79.24, 7.52————95% LoA
aNot applicable.
bLoA: limits of agreement.
cMVPA: moderate-to-vigorous physical activity.
dTST: total sleep time.
eWASO: wake after sleep onset.
Discussion
This investigation is one of the first studies to investigate the
reliability and accuracy of two consumer-level, wrist-based
activity trackers in the estimation of daily step count, total
calories expenditure, MVPA, and sleep parameters in a home
environment for a cohort of healthy older adults.
Results show that the mainstream monitors may be adopted to
estimate steps, energy expenditure, and some sleep parameters
(eg, TST) with a certain level of accuracy in a healthy older
adult population in free-living settings, whereas other variables
(MVPA and WASO) may show excessively large errors.
The measured mean values are largely consistent with data
reported studying the same population of interest in other studies
adopting non-consumer-level technologies for energy
expenditure [26], steps and MVPA [35], and sleep analysis [36].
Regarding step-counting performance, all the trackers presented
a good strength of agreement among one another and against
the reference device. Also, this study confirms previous findings
[17,18] indicating a slight overcounting by the Fitbit device and
an undercounting by the ActiGraph. In absolute terms, as shown
by the MAPE, there is no significant difference between the
Fitbit and the Garmin monitors when monitoring steps.
Similar considerations could be drawn for energy expenditure;
however, only the Fitbit shows moderate-to-good agreement
with the other trackers. The Fitbit underestimated energy
expenditure in our study, confirming findings illustrated in the
review by Feehan et al [37], which cited a number of studies in
which Fitbits worn on the wrist in free-living settings slightly
underestimated METs by 7% (when compared against doubly
labeled water), and showed a −10% measurement error (against
the SenseWear), and provided MAPE values varying from 16%
to 30% when compared with measurements from an ActiGraph
or Actiheart accelerometer. However, most of the studies
reviewed considered healthy adults and not older adults; thus,
the lower MAPE values reported in our study (mean 12.25%,
SD 7.33%) may be due to the generally limited amount of
moderate-to-vigorous activity performed by older adults. Fitbit
showed the narrowest limit of agreement among the trackers,
which indicated the device could underestimate the amount of
calories per day up to 750.34 kcal and overestimate up to 398.94
kcal.
Due to its many health benefits reported, MVPA may represent
an important aspect in people’s life and, with aging, this may
become even more useful to guarantee independent living and
prevention of noncommunicable diseases [35]. The current
national MVPA recommendations consider a threshold of 30
minutes per day or 150 minutes per week. Therefore, a correct
and reliable estimation of MVPA bouts helps support behavior
change techniques applied to sedentary older adults. All the
trackers considered (Fitbit, Garmin on the wrist, and
New-Lifestyles NL-2000i on the waist) were moderately
correlated with the reference. However, the Fitbit and Garmin
showed an excellent strength of agreement between each other.
The Fitbit and Garmin tended to overestimate MVPA with an
average error of 12.63 minutes per day and 13.8 minutes per
day, consistent with previously reported results [18], whereas
the New-Lifestyles NL-2000i underestimated by 11.7 minutes
per day. However, due to the limited moderate-to-vigorous
activities performed, MAPE values are large, especially for the
wrist-worn devices. The MAPE was mean 75.73% (SD 75.31%)
and mean 91.98% (SD 47.13%) for the Fitbit and Garmin,
respectively, confirming the large overestimation errors observed
in Fitbit devices estimating MVPA in free-living settings
compared with an ActiGraph accelerometer in healthy young
adults and older adults living with a variety of chronic diseases
(MAPEs >30%) [37]. The waist-worn device showed slightly
better results both in terms of MAPE and limits of agreement
(–47.85 to 24.45).
Finally, aging also impacts sleep, and changes occur in sleep
patterns with aging (for example, decrease in the amount of
slow wave sleep, increases in non-rapid eye movement sleep,
increase in the number of spontaneous arousals, changes in the
normal circadian sleep cycle) [38]. Moreover, older adults are
more prone to develop sleep-related respiratory disorders, which
are associated with cardiovascular disease, metabolic disorders,
and impaired neurocognition [38]. Thus, low-cost, unobtrusive,
and effective sleep monitoring devices such as consumer-level
activity trackers are ideal for providing insightful details on the
normal changes in sleeping patterns with advancing age.
Between the Fitbit and the Garmin, the Fitbit was moderately
correlated with the ActiGraph worn on the wrist, and only for
the estimation of the sleeping time. TST was overestimated by
a mean 5.72 minutes per day with a MAPE equal to 10.13%
(SD 9.12%), which are largely consistent with findings reported
in other studies adopting Fitbit devices to investigate sleep
measurement accuracy in healthy young adults in free-living
settings (MAPE approximately 10%) [37]. The Garmin showed
larger errors with a MAPE of 16.8% (SD 13.3%). In contrast,
WASO measurements were poorly correlated against the
ActiGraph for both devices. Although the lowest mean error
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was 0.21 minutes per day for the Fitbit, MAPE was large (mean
49.7%, SD 72%) due to the generally limited amount of time
spent awake overnight. Conversely, the Garmin significantly
underestimated the measurements. Limits of agreement were
similar for both trackers for both parameters. These
performances may not be suitable for clinical-grade
investigations because they require accurate measurements for
supporting the decision-making process. For example, WASO
is typically adopted as a criterion for discriminating insomnia
and normal-sleeper groups (the general threshold is WASO ≥31
minutes per day occurring at least three times per week for at
least 6 months) [39]; thus, the WASO estimation inaccuracy
may hinder the adoption of mainstream wristband devices for
clinical assessments in populations expected to have abnormal
sleep patterns [40].
It is worth clarifying that there is no universally accepted
definition of an acceptable degree of error for physical activity
wearable devices. Some studies recommend that an acceptable
measurement error under controlled conditions or for research
purposes is within ±3% [41,42] and under free-living conditions
is within ±10% [41,42]. Other studies recommend that mean
errors of less than 20% have acceptable validity for clinical
purposes [43]. This investigation considers the validity criteria
between the tested and criterion physical activity measures for
clinical purposes when the mean error is less than 20%. Results
suggest that the tested devices could be adopted to estimate
steps, energy expenditure, and sleep duration with an acceptable
level of accuracy in the population of interest, whereas clinicians
should be cautious in considering other parameters (eg, MVPA,
awakenings) for clinical and research purposes. Although
performance estimation is modest in some variables, it may still
be adequate for guidance purposes. For instance, the
ever-growing acceptance of wearable technologies by older
people may push the adoption of wrist-worn trackers in behavior
change investigations [11,44].
This study was limited to healthy older adults. As a
consequence, it is difficult to indicate if these findings are
generalizable to less active older adults or impaired or
hospitalized older adults. Indeed, as shown in the literature,
step-counting accuracy in people using a walking aid in a
laboratory-structured protocol represents a challenge for all
consumer-level trackers as evidenced by large MAPE values.
Moreover, the small number of studied participants and the
reduced intervention duration may also limit the generalizability
of these findings. Thus, further studies would be needed to
investigate activity trackers’ performance in a large cohort and
also in nonhealthy populations.
Although the most common commercial trackers were
considered in this study, it is difficult to indicate if results may
translate to other consumer monitors on the market, due to the
different algorithms they may employ.
This analysis was limited to some health parameters, whereas
other variables, which may be of interest in older adults, could
not be taken into account due to the lack of a gold-standard for
nonlaboratory settings. Some examples are sedentary bouts,
light activity bouts, the amount of time spent in different
postures, distance traveled, speed, additional sleep measures
(eg, sleep efficiency, sleep latency), and physiological measures,
such as continuous heart rate measurements, blood oxygen
saturation levels, galvanic skin response, blood pressure, or
photoplethysmography, and these should be further investigated
in future studies.
This study explored the performance of two wrist-worn trackers
(Fitbit Charge2 and Garmin vivosmart HR+) estimating steps,
energy expenditure, MVPA levels, and sleep parameters against
gold-standard technologies in a free-living environment in a
cohort of healthy participants aged 65 years and older.
This study confirmed that the wrist-worn devices are effective
in estimating steps, energy expenditure, and some sleep
parameters with a certain level of accuracy in healthy older
adults (lower MAPE values: 12.89% for step counting with the
Garmin, 12.25% for energy expenditure with the Fitbit, and
10.13% for TST estimation with the Fitbit). The results were
coherent with previous studies, and the observed accuracy was
acceptable for monitoring everyday activities. However,
clinicians should be cautious in considering other parameters
(eg, MVPA levels and WASO) for clinical and research
purposes.
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